News

Manual Drainage Fails to Prevent Lymphedema in Breast Cancer Patients


 

FROM THE SAN ANTONIO BREAST CANCER SYMPOSIUM

SAN ANTONIO – Adding manual lymph drainage to exercise therapy did not prevent lymphedema in a study of 160 breast cancer patients who underwent axillary lymph node dissection.

Researchers reported that the incidence of lymphedema following axillary lymph node dissection (ALND) was similar whether or not women had manual drainage in a randomized trial presented at the annual San Antonio Breast Cancer Symposium.

[Check out our comprehensive coverage of the San Antonio Breast Cancer Symposium.]

Based on these findings and previous data, "breast cancer patients have to perform exercise therapy immediately started after the axillary dissection to prevent arm lymphedema," said Nele Devoogdt, a physical therapist at University Hospitals Leuven in Belgium.

Manual lymph drainage involves stretching/massaging the skin around lymph nodes to improve resorption by the lymph capillaries, increase lymph transport (by stimulating lymph collectors), and to create collateral pathways of lymph transport, Ms. Devoogdt said. Although manual lymph drainage is used in several countries, including Belgium, to prevent lymphedema, the preventive effect has not been previously demonstrated in a peer-reviewed randomized trial.

For this study, the researchers recruited 160 breast cancer patients, who underwent ALND in one arm. Both arms were assessed prior to the procedure to assess the natural difference in size.

A total of 79 patients were randomized to exercise therapy and manual lymph drainage, while 81 patients had only exercise therapy. Both groups were given lifestyle guidelines for minimizing lymphedema.

Patients in both groups attended 1-2 sessions per week (29 exercise therapy sessions on average). In the treatment group, manual lymph drainage was performed 1-3 times per week (34 sessions on average).

At 1 month post-ALND, patients started treatment and an arm assessment was performed. Arm assessments followed at 3 months, 6 months (at which point treatment was stopped), and 12 months.

The primary outcome measure was the incidence of arm lymphedema – defined as a circumference increase of at least 2 cm at two successive measurements. The researchers found no significant difference in lymphedema incidence between the two groups at any time point. At 3 months, the incidence was 7% in the drainage group, compared with 5% in the exercise-only group; at 6 months, the incidence was 12% and 10%, respectively; and at 12 months, it was 23% and 18%.

Secondary outcomes also showed no significant differences in time to lymphedema, increase in arm volume, mental and physical health-related quality of life, and functional problems related to arm lymphedema.

The investigators reported that they have no relevant financial relationships.

Recommended Reading

Bevacizumab Maintenance Extends Lung Cancer Survival in Community Practice
MDedge Internal Medicine
Romidepsin Induces Complete Response in Peripheral T-Cell Lymphoma
MDedge Internal Medicine
Young Adult AML Patients Fare Better on Children's Protocol
MDedge Internal Medicine
Liposomal Cytarabine-Daunorubicin Improves AML Remission Rates
MDedge Internal Medicine
Chemotherapy Sequence Affects Early Breast Cancer Outcomes
MDedge Internal Medicine
No Increased Cancer Risk Seen in Stem Cell, Marrow Donors
MDedge Internal Medicine
Fentanyl Transmucosal Tablets Approved for Breakthrough Cancer Pain
MDedge Internal Medicine
Microscopic Vascular Invasion May Be a Powerful Prognosticator in Early Lung Cancer
MDedge Internal Medicine
Hormone Receptor Status Can Change in Breast Cancer
MDedge Internal Medicine
Adiposity Magnifies Adverse Cardiovascular Impact of Prophylactic Oophorectomy
MDedge Internal Medicine